BIT Life Sciences' WSA-2008 is a focused event for updating the current advances in worldwide R & D of Novel Antiviral Therapeutics. The anticipated attendees will represent top-level decision makers from leading biotech, pharmaceutical, and healthcare organizations. WSA-2008 is preparing to meet the demand on expert views, up-to-the-minute industry intelligence, and professional presentation, and poster sessions. WSA -2008 conference also provides an ideal forum for the promotion of relevant companies, products, technologies and services.
Explore
